dexmethylphenidate Focalin XR
Selected indexed studies
- Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride. (Drugs R D, 2002) [PMID:12455205]
- Focalin XR for ADHD. (Med Lett Drugs Ther, 2009) [PMID:19305368]
- Dexmethylphenidate. (Drugs, 2002) [PMID:12215063]
_Worker-drafted node — pending editorial review._
Connections
dexmethylphenidate Focalin XR is a side effect of
Sources
- Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. (2022) pubmed
- Dexmethylphenidate. (2002) pubmed
- Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder. (2005) pubmed
- Dexmethylphenidate--Novartis/Celgene. Focalin, D-MPH, D-methylphenidate hydrochloride, D-methylphenidate, dexmethylphenidate, dexmethylphenidate hydrochloride. (2002) pubmed
- Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder. (2014) pubmed
- Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder. (2009) pubmed
- Focalin XR for ADHD. (2009) pubmed
- Dexmethylphenidate (Focalin) for ADHD. (2002) pubmed
- Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. (2017) pubmed
- Risk of Major Malformations in Infants After First-Trimester Exposure to Stimulants: Results From the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications. (2023) pubmed